Literature DB >> 11281854

Pharmacology of phosphoinositides, regulators of multiple cellular functions.

T Balla1.   

Abstract

Inositol phospholipids represent a small fraction of the phospholipids present in all cellular membranes with remarkable importance in regulating various cell functions. They are synthesized from phosphatidylinositol by sequential phosphorylations on the several hydroxyls of the inositol ring to create polyphosphoinositides that function either as docking sites to promote formation of molecular signaling complexes, or serve as precursors for soluble inositol polyphosphates that act as diffusible intracellular messengers. Phosphoinositides are involved in the control of many processes, including membrane traffic, endo- and exocytosis, mitogenesis and apoptosis. Pharmacological tools have helped to clarify many details of phosphoinositide metabolism and have unveiled the roles of these lipids in the control of specific signaling pathways. However, because of their pleiotropic functions it has been questionable whether pharmacological manipulation of inositide formation and metabolism can be of therapeutic value. This review briefly summarizes the means by which inositide functions have been pharmacologically manipulated, and discusses possibilities for specifically targeting certain aspects of their regulatory functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281854     DOI: 10.2174/1381612013397906

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

1.  Target-specific PIP(2) signalling: how might it work?

Authors:  Nikita Gamper; Mark S Shapiro
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

2.  Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P₂.

Authors:  Eleonora Zakharian; Chike Cao; Tibor Rohacs
Journal:  FASEB J       Date:  2011-08-02       Impact factor: 5.191

3.  P5644 interacts with phosphatidylinositol-4-phosphate adaptor protein-1 associated protein-1.

Authors:  Xiao-Xia Ye; Hong Lu; Yao Yu; Ning Ding; Nai-Ling Zhang; Ke-Ke Huo; Da-Fang Wan; Yu-Yang Li; Jian-Ren Gu
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

4.  The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate.

Authors:  Bernd Nilius; Frank Mahieu; Jean Prenen; Annelies Janssens; Grzegorz Owsianik; Rudi Vennekens; Thomas Voets
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

5.  Insulin activates epithelial sodium channel (ENaC) via phosphoinositide 3-kinase in mammalian taste receptor cells.

Authors:  Arian F Baquero; Timothy A Gilbertson
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-24       Impact factor: 4.249

6.  Phospholipase C-mediated regulation of transient receptor potential vanilloid 6 channels: implications in active intestinal Ca2+ transport.

Authors:  Baskaran Thyagarajan; Bryan S Benn; Sylvia Christakos; Tibor Rohacs
Journal:  Mol Pharmacol       Date:  2008-12-10       Impact factor: 4.436

Review 7.  Regulation of transient receptor potential (TRP) channels by phosphoinositides.

Authors:  Tibor Rohacs; Bernd Nilius
Journal:  Pflugers Arch       Date:  2007-05-04       Impact factor: 3.657

8.  Phospholipase C δ4 regulates cold sensitivity in mice.

Authors:  Yevgen Yudin; Brianna Lutz; Yuan-Xiang Tao; Tibor Rohacs
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

9.  Modulation of the transient receptor potential channel TRPA1 by phosphatidylinositol 4,5-biphosphate manipulators.

Authors:  Yuji Karashima; Jean Prenen; Victor Meseguer; Grzegorz Owsianik; Thomas Voets; Bernd Nilius
Journal:  Pflugers Arch       Date:  2008-05-07       Impact factor: 3.657

10.  Temporal profiling of changes in phosphatidylinositol 4,5-bisphosphate, inositol 1,4,5-trisphosphate and diacylglycerol allows comprehensive analysis of phospholipase C-initiated signalling in single neurons.

Authors:  Carl P Nelson; Stefan R Nahorski; R A John Challiss
Journal:  J Neurochem       Date:  2008-08-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.